Updated:
Bio-Techne
Bio-Techne is a publicly traded life-sciences tools and diagnostics company headquartered in Minneapolis.
Bio-Techne
Finding new genes to power transformative cell therapies. | Finding new genes to power transformative cell therapies.
General information
Firm type
Asset Manager
Year founded
1976
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Minneapolis
Corporate office
Minneapolis, MN, United States
Principals
Chuck Kummeth
President and Chief Executive Officer
Sector focus
Frequently asked questions
Is Bio-Techne a single-family office or asset manager?
Bio-Techne is a publicly traded operating company listed on the NASDAQ. It develops and sells life-science reagents, instruments, and diagnostics — not investment management services. It does not match the structural definition of a family office or an asset manager and should not appear in an Altss-style allocator database.
What does Bio-Techne actually do?
The company supplies purified proteins, antibodies, immunoassays, and clinical diagnostic kits to pharmaceutical researchers, academic labs, and hospitals. Its products are used in drug discovery, basic biology research, and regulated clinical testing environments. The firm grows through internal product development and a history of bolt-on acquisitions in the life-sciences space.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: